<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01289795</url>
  </required_header>
  <id_info>
    <org_study_id>FF_NCRC_EPC01</org_study_id>
    <secondary_id>2009-010356-97</secondary_id>
    <nct_id>NCT01289795</nct_id>
  </id_info>
  <brief_title>Endothelial Function and Progenitor Cells in Acute Ischemic Stroke</brief_title>
  <acronym>EPCAS</acronym>
  <official_title>Endothelial Function and Progenitor Cells in Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether levels of circulating endothelial
      progenitor cells (cEPC) are increased in the acute phase of ischemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endothelial dysfunction is a key component of atherosclerosis which contributes to the
      development of cardio- and cerebrovascular diseases. However, endothelial dysfunction (ED) is
      not established as a risk factor for ischemic stroke.

      As a novelty the proposed trial investigates the following variety of indirect markers of
      endothelial function in acute ischemic stroke:

      circulating endothelial progenitor cells (EPC), endothelial microparticles (EMP), ENDOPAT
      (RH- PAT ratio) in two regards:

        1. time after ischemic events (&lt; 48h, Days 4-5, day 7 or at discharge)

        2. etiological stroke subtypes

      It is not known whether these parameters are changed after acute cerebral ischemia and could
      possibly serve as specific target for treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of cEPC</measure>
    <time_frame>&lt;48h, day 4-5, discharge or day 7</time_frame>
    <description>Levels of cEPC (CD34+/CD133+/VEGF2R+/CD31) in % of mononuclear cells using flow cytometry with respect to stroke subtypes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of EMP</measure>
    <time_frame>&lt;48h, day 4-5, day 7 or discharge</time_frame>
    <description>Levels of EMP (Annexin V+/CD31+; CD62E+) using flow cytometry with respect to stroke subtypes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ENDOPAT</measure>
    <time_frame>&lt;48h, day 4-5,day 7</time_frame>
    <description>Digital pulse volume change (with RH PAT as non invasive measurement (PAT-ratio; ENDOPAT, Itamar Medical Ltd.) for non-invasive, peripheral endothelial function</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>first-ever ischemic stroke</arm_group_label>
    <description>first-ever ischemic stroke according to the WHO definition</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, PBMC, plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with first-ever ischemic stroke transferred to our stroke unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with first ever ischemic stroke

          -  TIA, or transient symptoms with infarction (TSI)

          -  Age &gt; or = 18 years old within 24 hours after onset

          -  Written informed consent to participate

          -  No evidence for dysphagia

        Exclusion Criteria:

          -  Malignant hematopoietic disease (e.g. leukemia), severe systemic infections, severe
             immunological disease, renal or hepatic failure

          -  Pancreatitis, cholecystolithiasis, intestinal malabsorption

          -  Lactose intolerance

          -  Increased risk of aspiration

          -  Pregnancy

          -  Life expectancy less than 12 months

          -  Inability to give written informed consent

          -  Psychosis

          -  Alcohol dependency

          -  Abuse of illegal drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Endres, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Stroke Research Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Liman, MD</last_name>
    <phone>004930450560643</phone>
    <email>thomas.liman@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthias Endres, MD</last_name>
    <phone>004930450560102</phone>
    <email>matthias.endres@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Stroke Research Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Liman, MD</last_name>
      <phone>004930450560643</phone>
      <email>thomas.liman@charite.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Liman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2011</study_first_submitted>
  <study_first_submitted_qc>February 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2011</study_first_posted>
  <last_update_submitted>February 3, 2011</last_update_submitted>
  <last_update_submitted_qc>February 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Matthias Endres, MD</name_title>
    <organization>Center for Stroke Research Berlin</organization>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Cerebral Infarction</keyword>
  <keyword>Cerebrovascular Disorders</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Central Nervous System Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

